Furthermore, treatment of HNSCC cells with small molecule inhibitors THZ1, JQ1, OTX-015, and CPI-637 specifically reduced the mRNA and protein levels of IGF2BP2 by inhibiting the SE-associated transcriptional program. Here, IGF2BP2 is linked to head and neck squamous cell carcinoma.